Drugs / inhaled nitric oxide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00139217 | Aug 2005 → Sep 2007 | pulmonary hypertension | Emory University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | inhaled nitric oxide | “The primary objective of the trial is to determine the feasibility and clinical safety and efficacy of non-invasive inhaled nitric oxide in infants with PPHN without...” NCT00139217 ↗ |
| Known as | iNO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00139217 ↗ |
| Route | Intranasal | “delivered via nasal cannula” NCT00139217 ↗ |